In Table 1, we indicate the operative mechanisms of action of MIF and D-DT in MS, Alzheimer disease and glioblastoma and potential therapeutic anti-MIF/D-DT drugs that could block their pathogenic effects. The gene discussed is MIF; the disease is early-onset autosomal dominant Alzheimer disease.